In comparison, GRIN2A mutations have relatively higher prevalence in TCGA cohorts of lung adenocarcinoma, squamous cell carcinoma, or in cutaneous melanoma, and PIK3CA mutations, in lung adenocarcinoma and squamous cell carcinoma. Here, GRIN2A is linked to lung adenocarcinoma.